SPRY
SPRY
NASDAQ · Biotechnology

Ars Pharmaceuticals Inc

$8.17
-0.08 (-0.97%)
As of Mar 22, 10:13 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +706.7% upside
Low Target $44.11
Average Target $65.91
High Target $67.85
Current Price $8.17
Current
$8.17
Target
$65.91
$44.11 $65.91 avg $67.85
Scenario Analysis
Bear Case
$44.11
439.9%
Low target
Base Case
$65.91
+706.7%
Avg target
Bull Case
$67.85
+730.5%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$18.90
-56.8% from high
52-Week Low
$6.66
+22.7% from low
Target vs 52W High
$65.91
+248.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%